Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Achilles Therapeutics plc (ACHL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.8400+0.1300 (+4.80%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/24/2022
Current
6/30/20223/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
115.80M102.75M119.82M203.42M316.30M397.51M
Enterprise Value
-75.55M-122.17M-134.11M-65.04M31.89M254.32M
Trailing P/E
N/A0.43N/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
0.500.390.410.670.982.22
Enterprise Value/Revenue
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA
1.086.227.493.69-2.14-16.45

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-61.41%
S&P500 52-Week Change 3-16.88%
52 Week High 39.0000
52 Week Low 31.8400
50-Day Moving Average 32.8850
200-Day Moving Average 33.1253

Share Statistics

Avg Vol (3 month) 336.47k
Avg Vol (10 day) 320.28k
Shares Outstanding 540.77M
Implied Shares Outstanding 6N/A
Float 811.72M
% Held by Insiders 14.92%
% Held by Institutions 174.24%
Shares Short (Aug 30, 2022) 447.58k
Short Ratio (Aug 30, 2022) 41.24
Short % of Float (Aug 30, 2022) 4N/A
Short % of Shares Outstanding (Aug 30, 2022) 40.12%
Shares Short (prior month Jul 28, 2022) 453.2k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-15.07%
Return on Equity (ttm)-23.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -69.94M
Net Income Avi to Common (ttm)-65.82M
Diluted EPS (ttm)6.3500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)201.6M
Total Cash Per Share (mrq)4.94
Total Debt (mrq)10.12M
Total Debt/Equity (mrq)4.37
Current Ratio (mrq)11.45
Book Value Per Share (mrq)5.68

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement